BioCryst Pharmaceuticals - Rasio total nilai perusahaan marang pendapatan BCRX

BioCryst Pharmaceuticals, Inc. (BCRX) - logo korporat

The expansion of global reach among patients with rare pathologies is broadening the target market for BioCryst (BCRX). The enterprise value-to-revenue multiple clearly confirms this trend, with the latest value recorded as 2424.27. BioCryst is developing an ecosystem for the oral treatment of orphan diseases, creating barriers to entry for competitors. Additional potential is provided by diversification through antiviral developments and oncological research.

BioCryst (BCRX): Multiplikator EV/Sales saka 23.11.2025 nganti 19.11.2026

Rincian metrik keuangan lan pasar biocryst.com (BCRX)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:BCRX (BioCryst Pharmaceuticals)
Sampel barang BioCryst

Investors are assessing the resilience of BioCryst (BCRX) through the lens of market capitalization and debt load. The EV/Sales metric compares the total enterprise value with annual revenue, eliminating the impact of capital structure. The current EV/Sales value stands at 2424.27, reflecting market expectations. The trend of this indicator depends directly on the sales expansion of Orladeyo and the broadening of the drug portfolio. Low values signal an undervaluation of the company's potential within the orphan disease segment.

Pesaing langsung

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|VERA: Multiplikator EV/Sales|dianthustx.com (DNTH) - Multiplikator EV/Sales|PHVS (Pharvaris NV) - Multiplikator EV/Sales|ABCL: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PHAR (Pharming Corp)|nektar.com (NKTR) - Multiplikator nilai perusahaan marang pendapatan|UPB - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ZBIO (Zenas Biopharma)|IMNM: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gossamer Bio, Inc. (GOSS)|Rasio nilai perusahaan marang pendapatan KalVista Pharmaceuticals|Septerna Inc (SEPN) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PVLA|SVRA (Savara) - Nilai bisnis marang pendapatan|Rigel Pharma - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan AnaptysBio Corp (ANAB)|ATXS: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Rasio nilai perusahaan marang pendapatan|Aerovate Therapeutics Inc (JBIO) - Multiplikator EV/Sales|ACRS (Aclaris Therapeutics, Inc) - Multiplikator EV/Sales|Kyverna (KYTX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales TLSA|Nilai perusahaan marang pendapatan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Nilai perusahaan marang pendapatan|THTX: Rasio nilai perusahaan marang pendapatan|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD